Effect of cytokines on HIV-induced depletion of thymocytes in vivo

被引:30
作者
Uittenbogaart, CH [1 ]
Boscardin, WJ
Anisman-Posner, DJ
Koka, PS
Bristol, G
Zack, JA
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Microbiol Immunol & Mol Genet, AIDS Inst, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Sch Med, Dept Biostat, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med, Los Angeles, CA 90024 USA
关键词
cytokines; thymus; HIV infection; SCID-hu mice; interleukins; interferon-gamma;
D O I
10.1097/00002030-200007070-00003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Cytokines play an important role in the differentiation of thymocytes into mature T cells; consequently, certain cytokines could be useful for immune reconstitution after HIV infection without increasing viral load. Objective: To investigate whether cytokines affect immune depletion caused by HIV infection with a CXCR4-tropic strain in SCID-hu mice implanted with human fetal thymus and liver (thy/liv) tissue. Methods: The thy/liv implants were either mock infected or infected with HIV-1(NL4-3), a CXCR4-tropic molecular clone. Interleukin (IL)-2, IL-4, IL-7, interferon-gamma (IFN-gamma) or diluent was administered to the mice during the second and third week postinfection. Viral load and immunophenotype were determined in thymocytes. Results: Thymocyte subset distributions at 3 weeks postinfection were significantly influenced by treatment with certain cytokines. In particular, IL-2 caused the infected mice to retain a thymocyte profile that was more similar to that in mock-infected mice than that in diluent-treated infected mice, in that the percentages of immature CD4(+)CD8(+) and CD5(+)CD1(+) cells were slightly higher and much less variable than in diluent-treated infected mice. The effect of IFN-gamma treatment was similar to IL-2 but did not reach statistical significance. However, after IFN-gamma treatment, normal percentages of mature CD3(+)CD69(+) cells were maintained whereas this population was relatively increased in diluent-treated infected mice. Although treatment with IL-4 and IL-7 delayed depletion of immature thymocytes, these cytokines increased viral load. Conclusions: Cytokines such as IL-2 and IFN-gamma maintain immature thymocytes without increasing viral load and may be useful as adjuncts to improve immune reconstitution after HIV infection. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1317 / 1325
页数:9
相关论文
共 57 条
[31]   Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: Coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the post-entry level [J].
Pedroza-Martins, L ;
Gurney, KB ;
Torbett, BE ;
Uittenbogaart, CH .
JOURNAL OF VIROLOGY, 1998, 72 (12) :9441-9452
[32]  
Plum J, 1996, BLOOD, V88, P4239
[33]   Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development [J].
Res, P ;
Blom, B ;
Hori, T ;
Weijer, K ;
Spits, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :141-151
[34]   IDENTIFICATION OF A COMMON T-NATURAL-KILLER-CELL PROGENITOR IN HUMAN FETAL THYMUS [J].
SANCHEZ, MJ ;
MUENCH, MO ;
RONCAROLO, MG ;
LANIER, LL ;
PHILLIPS, JH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :569-576
[35]  
SCADDEN DT, 1997, J AQUIR IMMUNE DE S1, V16
[36]   A RAPID METHOD FOR MEASURING APOPTOSIS AND DUAL-COLOR IMMUNOFLUORESCENCE BY SINGLE LASER FLOW-CYTOMETRY [J].
SCHMID, I ;
UITTENBOGAART, CH ;
KELD, B ;
GIORGI, JV .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 170 (02) :145-157
[37]   DEAD CELL DISCRIMINATION WITH 7-AMINO-ACTINOMYCIN-D IN COMBINATION WITH DUAL COLOR IMMUNOFLUORESCENCE IN SINGLE LASER FLOW-CYTOMETRY [J].
SCHMID, I ;
KRALL, WJ ;
UITTENBOGAART, CH ;
BRAUN, J ;
GIORGI, JV .
CYTOMETRY, 1992, 13 (02) :204-208
[38]  
SCHNITTMAN SM, 1991, J IMMUNOL, V147, P2553
[39]   Concomitant therapy with subcutaneous interleukin-2 and zidovudine plus didanosine in patients with early stage HIV infection [J].
Simonelli, C ;
Zanussi, S ;
Sandri, S ;
Comar, M ;
Lucenti, A ;
Talamini, R ;
Bortolin, MT ;
Giacca, M ;
De Paoli, P ;
Tirelli, U .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (01) :20-27
[40]   EARLY STAGES IN HUMAN AND MOUSE T-CELL DEVELOPMENT [J].
SPITS, H .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (02) :212-221